Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.
about
Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patientsDrug Development in Alzheimer's Disease: The Contribution of PET and SPECTSerotonin, neural markers, and memory5-HT6 receptors and Alzheimer's diseaseMonoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesThe serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer's diseaseAcetylcholine influences growth cone motility and morphology of developing thalamic axonsLimited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's disease.Behavioral and psychological symptoms in Alzheimer's disease.Soluble beta amyloid(1-42): a critical player in producing behavioural and biochemical changes evoking depressive-related state?Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice.Combination of Pharmacophore Matching, 2D Similarity Search, and In Vitro Biological Assays in the Selection of Potential 5-HT6 Antagonists from Large Commercial Repositories.Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.Serotonin 6 receptor controls Alzheimer's disease and depressionAge effects on serotonin receptor 1B as assessed by PETThe serotonergic system and cognitive functionCurrent concepts in Alzheimer's disease: a multidisciplinary review.Management of behavioral problems in Alzheimer's disease.Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.Investigational drugs targeting 5-HT6 receptors for the treatment of Alzheimer's disease.Monoaminergic neuropathology in Alzheimer's disease.Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.BDNF val66met Polymorphism Impairs Hippocampal Long-Term Depression by Down-Regulation of 5-HT3 Receptors.Branched-chain amino acids and Alzheimer's disease: a Mendelian randomization analysis.A quantitative structure-activity relationship study on serotonin 5-HT6) receptor ligands: indolyl and piperidinyl sulphonamides.Apolipoprotein E gene, environmental risk factors, and their interactions in dementia among seniors.Behavioral and psychological symptoms in dementia is not a unitary concept: A critical review with emphasis on Alzheimer's disease.Design, synthesis and pharmacological evaluation of indolylsulfonamide amines as potent and selective 5-HT6 receptor antagonists.Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study.Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine.
P2860
Q24554505-6BDC4AC6-452D-4CE2-A1AE-B109355259B3Q26749755-2C137660-CB60-423D-A873-C1DB5ADE1CF8Q26800204-937FBC04-ED63-4042-9E70-EA6EFBED6A74Q27006820-4669F14B-2D86-41E8-91D4-3E545322D3EAQ28066691-E0328715-6F35-431F-AE1D-8CE8BB098B94Q28251394-E6968C86-342B-4C60-B976-5D6171E10B20Q30485794-0BCC094E-BB06-4929-A42C-BD95BBE7E890Q30637868-26E017DD-6431-433A-90E5-05DAC93798F1Q34009796-5DCB7501-E4BE-4D85-8C40-BFBC9AF6290CQ34078777-63C731E6-62DA-4EF2-A8ED-ACE4D1A36667Q35053378-4BBE03F7-223E-4DC3-963E-8E8E43952B8EQ35590479-C16C35DD-CACD-4AAB-80A5-BA7B3CB10647Q36020776-3B962F27-9437-42A1-B680-B63FB995D8DAQ36413592-9D027FB5-676B-415D-9A76-0F1756CD108CQ36950177-B2B4EE7B-A178-4531-A6F6-050F4563328DQ37245282-6F490AC8-E634-4CE0-8D23-F7695C309BF7Q37360292-E59C0912-0458-41A0-A7C4-88E80339C425Q37680018-B2DCC603-FA5C-4903-8BBC-6B47098D1BF3Q38209851-E6AA6D40-4691-4B96-927A-9E336B75FBE1Q38627971-5C5A0769-9472-480B-8C70-73A93655BADCQ38809649-D1772B5D-5FEE-4195-8313-953503C11A28Q39134334-8C09B84F-A18E-4DFE-B2E3-CBCA31E7D34AQ42517523-6CB0F19D-CB5A-4FB4-B971-B43ABE622114Q42670442-452A7D55-71B4-42E9-931E-22FCB04FD033Q43026448-AD8B33A8-ABF0-47B1-9C29-0A4CA5C5ADB7Q46019702-D264E123-A23A-4A68-A5AE-1C8B8E9E02D5Q46233237-68F2DC6E-9AD6-4F74-B727-84B25A910C50Q47786351-04B16FC6-C625-45FB-85D3-C55FBF6E5D28Q47881767-2958E2C9-B39A-44CD-A4D5-31D44800D2E2Q48055903-7BB30556-3ADF-4F87-8D46-4E37AB331D1EQ48130307-3C0E7995-5E34-47B7-B05E-219C03D95838Q55399027-6FA25259-AEE6-484A-A022-F74C5CC414E1
P2860
Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Differential involvement of 5-HT
@nl
Differential involvement of 5- ...... mptoms in Alzheimer's disease.
@en
type
label
Differential involvement of 5-HT
@nl
Differential involvement of 5- ...... mptoms in Alzheimer's disease.
@en
prefLabel
Differential involvement of 5-HT
@nl
Differential involvement of 5- ...... mptoms in Alzheimer's disease.
@en
P2093
P2860
P50
P356
P1476
Differential involvement of 5- ...... mptoms in Alzheimer's disease.
@en
P2093
B Lasheras
C P L-H Chen
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300330
P407
P577
2004-02-01T00:00:00Z